Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Nieuwkerk Pt"'
Autor:
Ngowi K, Pima F, Mmbaga BT, Aarnoutse RE, Reiss P, Nieuwkerk PT, Sprangers M, Sumari-de Boer M
Publikováno v:
Patient Preference and Adherence, Vol Volume 15, Pp 559-568 (2021)
Kennedy Ngowi,1,2 Francis Pima,1 Blandina Theophil Mmbaga,1,3,4 Rob E Aarnoutse,5 Peter Reiss,6,7 Pythia T Nieuwkerk,2 Mirjam Sprangers,2 Marion Sumari-de Boer1 1Kilimanjaro Clinical Research Institute, Moshi, Tanzania; 2Amsterdam UMC, Location AMC,
Externí odkaz:
https://doaj.org/article/704cec82901149f687627ad682d934e6
Autor:
Mmbaga Bt, Pima Fm, Ngowi Km, Mtesha B, Semvua Hh, Aarnoutse Re, Nieuwkerk Pt, Stellah G. Mpagama, Boer Ims, Chelangwa Gm
Background Adherence to TB treatment is challenging because of many factors. WHO has recommended the use of digital adherence monitoring technologies in its End-TB-strategy. However, there is paucity on its evidence in improving adherence. EvriMED a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45e6ee8ab076f45918ddd6340abbadcd
https://doi.org/10.21203/rs.2.399/v1
https://doi.org/10.21203/rs.2.399/v1
Autor:
Been, SK, van de Vijver, DA, Nieuwkerk, PT, Pogány, K., Brito, I., Wolfers, M., Stutterheim, SE, Bos, AER, Verbon, A.
Publikováno v:
Been, SK, van de Vijver, DA, Nieuwkerk, PT, Pogány, K, Brito, I, Wolfers, M, Stutterheim, SE, Bos, AER & Verbon, A 2015, ' ROtterdam ADherence (ROAD) project; characteristics and risk factors for non-adherence to cart in immigrants with HIV ', 12th International AIDS Impact Conference, Amsterdam, Netherlands, 28/07/15-31/07/15 . < https://www.aidsimpact.com/2015/Academics/Programme/abstract/?id=2183 >
ISSUE=12;TITLE=12th International AIDS Impact Conference
ISSUE=12;TITLE=12th International AIDS Impact Conference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d1bf5b0f5110f2a8ef83b3191089c9d0
https://research.ou.nl/en/publications/ffda70a5-a68d-44d6-9093-4f3e24d9ccc8
https://research.ou.nl/en/publications/ffda70a5-a68d-44d6-9093-4f3e24d9ccc8
Autor:
Pogany, K, Vanvalkengoed, IG, Prins, JM, Nieuwkerk, PT, Ende, Marchina, Kauffman, RH, Kroon, FP, Verbon, A, Nievaard, MF, Lange, JMA, Brinkman, K
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 44(4), 395-400. Lippincott Williams and Wilkins
Jaids. Journal of Acquired Immune Deficiency Syndromes, 44(4), 395-400. Lippincott Williams & Wilkins
Jaids. Journal of Acquired Immune Deficiency Syndromes, 44(4), 395-400. Lippincott Williams & Wilkins
Objective: To evaluate the safety and efficacy of discontinuing highly active antiretroviral therapy (HAART) in HFV-1-positive patientswho initiated HAART at a CD4(+) T-cellcount > 350cells mm(3). Methods: Eligible patients were identified from the D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0c194417a0840173df22843e95902438
https://pure.amc.nl/en/publications/effects-of-active-treatment-discontinuation-in-patients-with-a-cd4-tcell-nadir-greater-than-350-cellsmm3(78fabca2-8971-4f3f-b13a-a4bae883ef11).html
https://pure.amc.nl/en/publications/effects-of-active-treatment-discontinuation-in-patients-with-a-cd4-tcell-nadir-greater-than-350-cellsmm3(78fabca2-8971-4f3f-b13a-a4bae883ef11).html
Autor:
Burger, DM, Hugen, PWH, Aarnoutse, RE, Hoetelmans, RMW, Jambroes, M, Nieuwkerk, PT, Schreij, G, Schneider, MME, Ende, Marchina, Lange, JMA, Gyssens, ICJ (Inge), de Marie, S (Siem)
Publikováno v:
Therapeutic Drug Monitoring, 25, 73-80
Therapeutic drug monitoring, 25(1), 73-80. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 25, 1, pp. 73-80
Therapeutic Drug Monitoring, 25, 73-80. Lippincott Williams & Wilkins
Therapeutic drug monitoring, 25(1), 73-80. Lippincott Williams and Wilkins
Therapeutic Drug Monitoring, 25, 1, pp. 73-80
Therapeutic Drug Monitoring, 25, 73-80. Lippincott Williams & Wilkins
Contains fulltext : 119497.pdf (Publisher’s version ) (Closed access) The relationship between plasma concentrations of nelfinavir and virologic treatment failure was investigated to determine the minimum effective concentration of nelfinavir. Plas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1a6e2771977a6e281d3a28f2a02754
http://hdl.handle.net/2066/119497
http://hdl.handle.net/2066/119497
Autor:
Kooiman, ELM, Dieleman, Jeanne, Gyssens, ICJ (Inge), Nieuwkerk, PT, de Marie, S (Siem), Ende, Marchina
Publikováno v:
Nederlands Tijdschrift voor Geneeskunde, 146, 1183-1187. Bohn Stafleu van Loghum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::f6e62c6f6306c558f61e5109b922625b
https://pure.eur.nl/en/publications/c9bfb236-220d-4c60-9b3a-2d9f7d6f204c
https://pure.eur.nl/en/publications/c9bfb236-220d-4c60-9b3a-2d9f7d6f204c
Autor:
Nieuwkerk, PT, Sprangers, MAG, Burger, DM, Hoetelmans, RMW, Hugen, PWH, Danner, SA, Ende, Marchina, Schneider, MME, Schrey, G, Meenhorst, PL, Sprenger, HG, Kauffmann, RH, Jambroes, M, Chesney, MA, de Wolf, F, Lange, JMA
Publikováno v:
Archives of Internal Medicine, 161, 1962-1968. American Medical Association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::effce2e2d7f318b10b4a57132a2acd3b
https://pure.eur.nl/en/publications/ab09c5a9-bb7c-4d88-8ae1-81f6619eb917
https://pure.eur.nl/en/publications/ab09c5a9-bb7c-4d88-8ae1-81f6619eb917
Autor:
Langebeek, N, Sprenger, HG, Gisolf, EH, Reiss, P, Sprangers, MAG, Legrand, JC, Richter, C, Nieuwkerk, PT
Publikováno v:
HIV Medicine; May2014, Vol. 15 Issue 5, p286-290, 5p
Autor:
Musters AM, Koot YE, van den Boogaard NM, Kaaijk E, Macklon NS, van der Veen F, Nieuwkerk PT, Goddijn M
Publikováno v:
Human Reproduction; Feb2013, Vol. 28 Issue 2, p398-405, 8p
Autor:
Grijsen, Ml, Koster, Gt, Vonderen, Mga, Van Kasteren, M, Kootstra, Gj, Steingrover, R, De Wolf, F, Prins, Jm, Nieuwkerk, Pt
Publikováno v:
HIV Medicine; Nov2012, Vol. 13 Issue 10, p630-635, 6p, 2 Graphs